Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke (SVO70)

NCT06649240 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT06649240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06649240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke (SVO70)
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 4, 2024
Completion date
September 30, 2030
Enrollment
4,016 (estimated)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, cholesterol, ldl, ischemic stroke, secondary prevention, small vessel cerebrovascular disease